Form 8-K - Current report:
SEC Accession No. 0000950170-24-107824
Filing Date
2024-09-18
Accepted
2024-09-18 16:34:49
Documents
20
Period of Report
2024-09-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aktx-20240913.htm   iXBRL 8-K 73940
2 EX-10.1 aktx-ex10_1.htm EX-10.1 27335
3 EX-99.1 aktx-ex99_1.htm EX-99.1 467784
4 GRAPHIC img218604663_0.jpg GRAPHIC 66503
5 GRAPHIC img218604663_1.jpg GRAPHIC 92654
6 GRAPHIC img218604663_2.jpg GRAPHIC 88399
7 GRAPHIC img218604663_3.jpg GRAPHIC 119457
8 GRAPHIC img218604663_4.jpg GRAPHIC 132294
9 GRAPHIC img218604663_5.jpg GRAPHIC 112649
10 GRAPHIC img218604663_6.jpg GRAPHIC 99821
  Complete submission text file 0000950170-24-107824.txt   1850243

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aktx-20240913.xsd EX-101.SCH 97668
22 EXTRACTED XBRL INSTANCE DOCUMENT aktx-20240913_htm.xml XML 6056
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: 8-K | Act: 34 | File No.: 001-36288 | Film No.: 241307980
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)